全文获取类型
收费全文 | 1517998篇 |
免费 | 109418篇 |
国内免费 | 3564篇 |
专业分类
耳鼻咽喉 | 21674篇 |
儿科学 | 45116篇 |
妇产科学 | 42493篇 |
基础医学 | 211018篇 |
口腔科学 | 44022篇 |
临床医学 | 130381篇 |
内科学 | 301065篇 |
皮肤病学 | 32689篇 |
神经病学 | 123785篇 |
特种医学 | 59718篇 |
外国民族医学 | 448篇 |
外科学 | 236733篇 |
综合类 | 34062篇 |
现状与发展 | 8篇 |
一般理论 | 714篇 |
预防医学 | 109310篇 |
眼科学 | 35119篇 |
药学 | 112815篇 |
5篇 | |
中国医学 | 3285篇 |
肿瘤学 | 86520篇 |
出版年
2018年 | 15268篇 |
2017年 | 12404篇 |
2016年 | 13590篇 |
2015年 | 15417篇 |
2014年 | 22021篇 |
2013年 | 33043篇 |
2012年 | 44422篇 |
2011年 | 47350篇 |
2010年 | 27903篇 |
2009年 | 26659篇 |
2008年 | 45503篇 |
2007年 | 49292篇 |
2006年 | 49380篇 |
2005年 | 48634篇 |
2004年 | 47168篇 |
2003年 | 45329篇 |
2002年 | 44455篇 |
2001年 | 65271篇 |
2000年 | 66631篇 |
1999年 | 57152篇 |
1998年 | 17094篇 |
1997年 | 15572篇 |
1996年 | 14899篇 |
1995年 | 13927篇 |
1994年 | 12996篇 |
1992年 | 43821篇 |
1991年 | 42274篇 |
1990年 | 41470篇 |
1989年 | 40387篇 |
1988年 | 37863篇 |
1987年 | 37297篇 |
1986年 | 35779篇 |
1985年 | 34085篇 |
1984年 | 26122篇 |
1983年 | 22303篇 |
1982年 | 14239篇 |
1981年 | 12953篇 |
1979年 | 24610篇 |
1978年 | 17873篇 |
1977年 | 15640篇 |
1976年 | 14105篇 |
1975年 | 15859篇 |
1974年 | 18674篇 |
1973年 | 18075篇 |
1972年 | 17187篇 |
1971年 | 16011篇 |
1970年 | 15201篇 |
1969年 | 14555篇 |
1968年 | 13629篇 |
1967年 | 12184篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
133.
Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient
下载免费PDF全文
![点击此处可从《Journal of clinical pharmacy and therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
134.
As countries implement Article 11 of the World Health Organization (WHO) Framework Convention on Tobacco Control, graphic warning labels that use images of people and their body parts to illustrate the consequences of smoking are being added to cigarette packs. According to exemplification theory, these case examples—exemplars—can shape perceptions about risk and may resonate differently among demographic subpopulations. Drawing on data from eight focus groups (N = 63) with smokers and nonsmokers from vulnerable populations, this qualitative study explores whether people considered exemplars in their reactions to and evaluations of U.S. graphic health warning labels initially proposed by the Food and Drug Administration. Participants made reference to prior and concurrent mass media messages and exemplars during the focus groups and used demographic cues in making sense of the images on the warning labels. Participants were particularly sensitive to age of the exemplars and how it might affect label effectiveness and beliefs about smoking. Race and socioeconomic status also were salient for some participants. We recommend that exemplars and exemplification be considered when selecting and evaluating graphic health warnings for tobacco labels and associated media campaigns. 相似文献
135.
John Lennon Silva Cunha Amanda Almeida Leite Thamiris de Castro Abrantes Lorena Passoni Vervloet Thayn Melo de Lima Morais Gerson de Oliveira Paiva Neto Tatiana Nayara Librio Kimura Snia Maria Soares Ferreira Ricardo Luiz Cavalcanti de Albuquerque‐Júnior Aline Corrêa Abraho Mario Jos Romaach Bruno Augusto Benevenuto de Andrade Oslei Paes de Almeida Ciro Dantas Soares 《Journal of cutaneous pathology》2021,48(1):24-33
136.
best practice onkologie - 相似文献
137.
138.
139.
Altan Ahmed John A. Stauffer Jordan D. LeGout Justin Burns Kristopher Croome Ricardo Paz-Fumagalli Gregory Frey Beau Toskich 《Journal of gastrointestinal oncology.》2021,12(2):751
BackgroundNeoadjuvant yttrium-90 transarterial radioembolization (TARE) is increasingly being used as a strategy to facilitate resection of otherwise unresectable tumors due to its ability to generate both tumor response and remnant liver hypertrophy. Perioperative outcomes after the use of neoadjuvant lobar TARE remain underinvestigated.MethodsA single center retrospective review of patients who underwent lobar TARE prior to major hepatectomy for primary or metastatic liver cancer between 2007 and 2018 was conducted. Baseline demographics, radioembolization parameters, pre- and post-radioembolization volumetrics, intra-operative surgical data, adverse events, and post-operative outcomes were analyzed.ResultsTwenty-six patients underwent major hepatectomy after neoadjuvant lobar TARE. The mean age was 58.3 years (17–88 years). 62% of patients (n=16) had primary liver malignancies while the remainder had metastatic disease. Liver resection included right hepatectomy or trisegmentectomy, left or extended left hepatectomy, and sectorectomy/segmentectomy in 77% (n=20), 8% (n=2), and 15% (n=4) of patients, respectively. The mean length of stay was 8.3 days (range, 3–33 days) and there were no grade IV morbidities or 90-day mortalities. The incidence of post hepatectomy liver failure (PHLF) was 3.8% (n=1). The median time to progression after resection was 4.5 months (range, 3.3–10 months). Twenty-three percent (n=6) of patients had no recurrence. The median survival was 28.9 months (range, 16.9–46.8 months) from major hepatectomy and 37.6 months (range, 25.2–53.1 months) from TARE.ConclusionsMajor hepatectomy after neoadjuvant lobar radioembolization is safe with a low incidence of PHLF. 相似文献
140.